The Circulating Level of FABP3 Is an Indirect Biomarker of MicroRNA-1
Authors:
- Barbara GarganoBGBarbara Gargano
- Pierluigi CarulloPCPierluigi Carullo
- Dario Di SilvestreDario Di Silvestre
- Antonella De PalmaAntonella De Palma
- Ludovica GrassoLGLudovica Grasso
- Carolina Di SommaCSCarolina Di Somma
- Pierluigi MauriPierluigi Mauri
- Louise BenazziLBLouise Benazzi
- Anna FranzoneAFAnna Franzone
- Gloria Saccani JottiGJGloria Saccani Jotti
- Marie-Louise BangMarie-Louise Bang
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of Health (GR-2007-682438, RFSDO-2007-627952, RFPS-2007-2-644709)
- Fondazione Cariplo (2007_5312 12431, 12-4-5157157-31)
- Telethon (S07006TELA)
- Fondation Leducq
This publication has 24 references indexed in Scilit:
- SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathwayEuropean Heart Journal, 2012
- MicroRNAs in cardiac diseaseTranslational Research, 2011
- A Genome-Wide Screen Reveals a Role for microRNA-1 in Modulating Cardiac Cell PolarityDevelopmental Cell, 2011
- Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological ConditionsCirculation, 2009
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2Nature Medicine, 2007
- Acromegaly and the Cardiovascular SystemNeuroendocrinology, 2006
- Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Dance Band on the TitanicCirculation Research, 2002